Progyny (PGNY) director Debra L. Morris granted RSUs and options in lieu of cash
Rhea-AI Filing Summary
Progyny, Inc. director Debra L. Morris reported routine equity compensation awards. She received 5,660 restricted stock units (RSUs), each representing one share of common stock, bringing her reported common stock holdings to 5,660 shares. The filing also shows two stock option grants covering 27,119 and 3,203 shares of common stock at an exercise price of $24.69 per share. According to the footnotes, these RSUs and options vest on the earlier of May 21, 2027 or the day before Progyny’s first annual stockholders’ meeting following the grant date, contingent on her continued board service. One option grant was issued in lieu of a $39,990 annual cash retainer for board and committee service.
Positive
- None.
Negative
- None.
Insights
Routine director equity awards with no open-market buying or selling.
The filing shows Debra L. Morris, a director of Progyny, Inc., receiving RSUs and stock options as part of standard board compensation, including an option issued instead of a $39,990 cash retainer. All transactions are coded as grants (A), not market trades.
The RSUs and options vest on the earlier of May 21, 2027 or the day before the first annual stockholders’ meeting following the grant date, subject to continued service. This structure aligns her incentives with long-term shareholder value but does not add near-term trading signals.
There are no derivative exercises, sales, or tax-withholding dispositions in this filing, and derivativeSummary is empty after these grants. As a result, the activity appears to be routine, compensation-related equity issuance rather than a change in the director’s market view of PGNY.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 3,203 | $12.49 | $40K |
| Grant/Award | Stock Option (Right to Buy) | 27,119 | $0.00 | -- |
| Grant/Award | Common Stock | 5,660 | $0.00 | -- |
Footnotes (1)
- Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. The option was issued to the Reporting Person in lieu of an annual cash retainer of $39,990 for board and committee service. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.